The study of immune checkpoint inhibitors in chronic hepatitis B virus infection

被引：7
|
作者：
Li, Siyu [1 ]
Li, Na [1 ]
Yang, Shanru [1 ,2 ]
Deng, Haiyan [1 ]
Li, Yanguo [3 ]
Wang, Yixuan [1 ]
Yang, Jiaqiang [1 ]
Lv, Jiaxin [1 ]
Dong, Lan [1 ]
Yu, Guansen [1 ]
Hou, Xin [1 ]
Wang, Geng [1 ]
机构：
[1] Ningbo Univ, Sch Med, Ningbo 315211, Peoples R China
[2] Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China
[3] Ningbo Univ, Inst Drug Discovery Technol, Ningbo, Peoples R China
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2022年 / 109卷
基金：
中国国家自然科学基金; 中国博士后科学基金;
关键词：
Hepatitis B virus; Chronic hepatitis B; Immune checkpoint inhibitors; CD8; T-CELLS; UP-REGULATION; THERAPEUTIC VACCINATION; AUTOIMMUNE-DISEASES; VIRAL-HEPATITIS; TIM-3; EXPRESSION; PD-1; ACTIVATION; BLOCKADE;
D O I：
10.1016/j.intimp.2022.108842
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Chronic hepatitis B (CHB) is a contagious disease caused by the hepatitis B virus, which can damage the liver via cirrhosis or cancer. Existing CHB treatments are not completely effective; immune checkpoint inhibitors show potential hope for treating CHB, but their safety and efficacy need to be further validated. In this review, we introduce the mechanisms of CHB virus infection, the expression of immune checkpoints during CHB, and the treatments that are currently available. Finally, we discuss the possibilities for using immune checkpoint inhibitors to treat CHB.
引用
收藏
页数：9
相关论文
共 50 条
  • [31] The Concept of Immune Tolerance in Chronic Hepatitis B Virus Infection Is Alive and Well
    Milich, David R.
    GASTROENTEROLOGY, 2016, 151 (05) : 801 - 804
  • [32] Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection
    Ortega-Prieto, Ana Maria
    Dorner, Marcus
    VACCINES, 2017, 5 (03)
  • [33] Immune system and hepatitis B virus infection
    Hui, Chee-Kin
    Lau, George K. K.
    JOURNAL OF CLINICAL VIROLOGY, 2005, 34 : S44 - S48
  • [34] Immune Response in Hepatitis B Virus Infection
    Tan, Anthony
    Koh, Sarene
    Bertoletti, Antonio
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (08): : 1 - 18
  • [35] Immune responses in hepatitis B virus infection
    Rehermann, B
    SEMINARS IN LIVER DISEASE, 2003, 23 (01) : 21 - 37
  • [36] Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
    Shah, Neil J.
    Al-Shbool, Ghassan
    Blackburn, Matthew
    Cook, Michael
    Belouali, Anas
    Liu, Stephen V.
    Madhavan, Subha
    He, Aiwu Ruth
    Atkins, Michael B.
    Gibney, Geoffrey T.
    Kim, Chul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [37] Chronic Hepatitis B and Hepatitis D Virus Infection
    Rusignuolo, Giuseppe
    Thimme, Robert
    Neumann-Haefelin, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (16) : 948 - 954
  • [38] Hepatitis B virus infection, hepatitis B vaccine, and hepatitis B immune globulin
    Zimmerman, RK
    Ruben, FL
    Ahwesh, ER
    JOURNAL OF FAMILY PRACTICE, 1997, 45 (04): : 295 - 315
  • [39] Hepatitis D virus infection in Slovenian patients with chronic hepatitis B virus infection: A national prevalence study
    Hosnjak, L.
    Jelen, M. M.
    Stunf, S.
    Zagozen, A.
    Komlos, K. Fujs
    Markocic, P.
    Seme, K.
    Poljak, M.
    JOURNAL OF CLINICAL VIROLOGY, 2016, 82 : S16 - S16
  • [40] Hepatitis B Virus Reactivation in Cancer Patients Undergoing Immune Checkpoint Inhibitors Therapy: A Systematic Review
    Zhao, Jian
    Zhang, Yuehua
    Qin, Siyuan
    Zou, Bingwen
    Wang, Yongsheng
    JOURNAL OF CANCER, 2022, 13 (14): : 3539 - 3553
12345